Atlas Trials

Ketamine and Lidocaine Infusion in Refractory Chronic Migraine

Clinical trial NCT06935552 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06935552
Sponsor
Assiut University
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Refractory Chronic Migraine
Start date
2025-06-01
Primary completion
2026-11-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.